MYRIAD GENETICS INC — Director's Dealing 2023

Mar 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2023-03-01

Reporting Person: Hart Jayne B. (See Remarks)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	172562	Direct

Footnotes

F1: The holdings for the Reporting Person include one additional share that was acquired on November 30, 2022 under the Myriad Genetics, Inc. 2012 Amended and Restated Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).